UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000062183
Receipt number R000063235
Scientific Title COMPASS-Insomnia NS study
Date of disclosure of the study information 2026/07/14
Last modified on 2026/07/09 09:38:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the Effectiveness of Lifestyle Improvement Support to Sleep Quality Based on Sleep Sensor Data in Community Pharmacies

Acronym

COMPASS-Insomnia NS study

Scientific Title

COMPASS-Insomnia NS study

Scientific Title:Acronym

COMPASS-Insomnia NS study

Region

Japan


Condition

Condition

Sleep Disorder, Insomnia

Classification by specialty

Medicine in general Psychosomatic Internal Medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Develop a simple and highly effective "sleep hygiene guidance" program that can be implemented in community pharmacies, and use sleep sensor data to verify its effectiveness.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Sleep quality (sleep efficiency, Athens Insomnia Scale score, RU-STAD score)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Lifestyle improvement support based on sleep hygiene and health behavioral science by pharmacists in community pharmacies.

Interventions/Control_2

Usual care

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients on medication for insomnia.
2) Patients age 18 years and older.
3) Patients who are able to use the non-wearable sleep sensor continuously during the study period.

Key exclusion criteria

1) Patients with prescriptions for psychiatric or anti-dementia medications.
2) Patients who have difficulty participating in the study on a continuous basis (approximately 3 months).
3) Patients who are employed in shift work.
4) Other patients who are deemed by the principal investigator to be inappropriate to participate in the study.

Target sample size

70


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Okada

Organization

Wakayama Medical University

Division name

School of Pharmaceutical Sciences

Zip code

6408156

Address

25-1 Nanabancho Wakayama

TEL

0734881843

Email

okada.hiroshi.28z@kyoto-u.jp


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name Okada

Organization

Wakayam Medical University

Division name

School of Pharmaceutical Sciences

Zip code

6408156

Address

25-1Nanabancho Wakayama

TEL

0734881843

Homepage URL


Email

okada.hiroshi.28z@kyoto-u.jp


Sponsor or person

Institute

Wakayama Medical University

Institute

Department

Personal name



Funding Source

Organization

Ministry of Education, Culture, Sports, Science and Technology

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Health Organization, Kyoto Medical Center

Address

1-1 Fushimi-ku Fukakusa Mukaihata-cho, Kyoto

Tel

075-641-9161

Email

bufobufo.ok@gmail.com


Secondary IDs

Secondary IDs

YES

Study ID_1

23-078

Org. issuing International ID_1

Kyoto Medical Center

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 07 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

35

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 03 Month 01 Day

Date of IRB

2023 Year 03 Month 18 Day

Anticipated trial start date

2024 Year 10 Month 01 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 07 Month 09 Day

Last modified on

2026 Year 07 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063235